The III Clinicl Trial for Stem Cell Treatment for Spinal Cord Injury Has Been Applied and Successfully Approved by FDA for The First Time in The World

Cells Center China has successfully accomplished the second trial for stem cell treatment for spinal cord injury, and started the third clinicl trial for stem cell treatment for spinal cord injury with the approval FDA (Food and Drug Administration) of US, which marks that Cells Center China has the international leading level in stem cell treatment for spinal cord injury.
Risks for SCI
The spinal cord injury (SCI) refers to any injury to the spinal cord that is caused by trauma, such as accident, which will lead to a range of symptoms in the corresponding section of the spinal cord, such as motor dysfunction, sense dysfunction, myodystony, and changes in pathological reflex. SCI usually affects people below 30 years old, and makes them lie on bed for a long time, which increases the risk for many complications. SCI may significantly affect the health and life quality of patients, and usually the survival rate of traumatic SCI is lowered 30% than natural population.
Why choose Cells Center China
In 2000, PhD. An Yi-Hua and his expert team started basic research on stem cell with the support and help of Wang Zhong-cheng, Academician of Chinese Academy of Engineering and headquarters of armed police forces.
In 2003, PhD. An Yi-Hua and his expert team successfully accomplished the first trial on stem cell treatment for of quadrumana’ cerebral hemorrhage sequelae in the world, and creatively build up the standard operation procedure (SOP) for cells cultivating, filtering, induced differentiation in laboratory.
In 2004, Cells Center China was established in Beijing, China, which is the first in the world, and experienced in the combination of the stem cell research and treatment for spinal cord injury. Up to now, more than 2,000 patients with SCI were benefited from stem cell treatment and 30 patients were under treatment in bed.
The Latest Breakthrough in Stem Cell Treatment for Spinal Cord Injury
The scientific and standardized research management turn out important as stem cell treatment for spinal cord injury was be applied in clinic from a basic research. In 2010, with the most strict regulation on clinical trial of WHO and FDA, Cells Center China submitted the relevant clinical trial programs on stem cell treatment for central neural damage to committee of experts of the first class registration platform of China and FDA of US.
Besides, Cells Center China made international standard management for clinical trial programs of human body for the first time in China, and came up with in international community the specificity of Chinese patients on performing stem cell treatment.
Up to now, Cells Center China has started as scheduled 20 clinical trials approved by WHO, and 6 clinical trials approved by FDA, and accomplished successfully 11 clinical trials on stem cell treatment for cerebral palsy and spinal cord injury in its the first and second stages.
The third clinical trial of stem cell treatment for spinal cord injury which is submitted in 2012, has been approved. And the third clinical trial of stem cell treatment for cerebral palsy, traumatic brain injury sequelae, Cerebral hemorrhage sequelae, and sequel of cerebral infarction will be accomplished in succession.

Want more about stem cell treatment for spinal cord injury, please email us at stemcellprc@gmail.com.